Printer Friendly

CEL-SCI CORPORATION UNDERWRITERS EXERCISE OVER-ALLOTMENT OPTION

 CEL-SCI CORPORATION UNDERWRITERS EXERCISE OVER-ALLOTMENT OPTION
 ALEXANDRIA, Va., March 23 /PRNewswire/ -- CEL-SCI Corporation (NASDAQ: CELI) today announced that Kober Financial Corp., as the representative of the underwriters of CEL-SCI Corporation's recently completed public offering, exercised in full their over-allotment option to purchase an additional 135,000 units. This brings the total number of units sold in the public offering to 1,035,000 units.
 The underwriters' over-allotment option was included in CEL-SCI's stock underwriting completed on Feb. 6, 1992. The over-allotment units were sold at $15.50, less the underwriting discount and expense allowance, and provided additional net proceeds of $1.85 million. The total net proceeds to CEL-SCI from the offering were $14 million. The proceeds of the offering will be used to finance the continued research and development, including clinical trials, of the company's planned therapeutic products.
 CEL-SCI Corporation is a biopharmaceutical company with its focus on the human immune system. Human clinical trials are ongoing using the company's proprietary drugs in the fields of cancer and AIDS.
 -0- 3/23/92
 /CONTACT: Matt Haines of Strategic Growth International, 212-826-9622, for CEL-SCI/
 (CELI) CO: CEL-SCI International ST: Virginia IN: MTC SU:


TW-SB -- DC010 -- 0442 03/23/92 09:38 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 23, 1992
Words:202
Previous Article:SEPTA INFORMATION FAIR SET FOR MARCH 24 AT GALLERY
Next Article:BANC ONE COMPLETES PURCHASE OF FIVE DIAMOND MORTGAGE LOAN OFFICES
Topics:


Related Articles
UNDERWRITERS' OPTION EXERCISED IN ARAMED UNIT OFFERING AND GENSIA COMMON STOCK OFFERING
AFFYMAX ANNOUNCES UNDERWRITERS HAVE EXERCISED OVER-ALLOTMENT OPTION OF 600,000 SHARES
CEL-SCI CORPORATION ANNOUNCES PUBLIC OFFERING OF SECURITIES
CEL-SCI CORPORATION LOWERS EXERCISE PRICE OF PUBLICLY HELD WARRANTS
CEL-SCI Repurchases $2.85 Million of Its Stock
CEL-SCI Corporation Announces Results of Annual Meeting and Plans to Shift to AMEX
CEL-SCI Corporation Announces Improvement In Terms of its Publicly Held Warrants
CEL-SCI Corporation Completes $10 Million Financing
CEL-SCI Corporation Approved for Trading on Berlin Stock Exchange
CEL-SCI Aware of No Developments to Account for Recent Stock Activity

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters